Skip to main content
. 2021 Jan 13;29(1):32–43.e4. doi: 10.1016/j.chom.2020.10.011

Table 1.

Mutations Identified in Multiple Individuals

Mutationa Individualsb Group Typec Region Fraction of cVDPVd
A481G 72 Gatekeeper Noncoding 5′ UTR 1
U2909C 25 Gatekeeper NS VP1 0.75
A2908G 19 Gatekeeper NS VP1 0.03
U398C 16 Gatekeeper Noncoding 5′ UTR 0.94
A2074G 12 Capsid NS VP3 0.01
A2992G 11 Capsid NS VP1 0.03
A2986G 10 Antigenic NS VP1 0.01
G6084U 10 3D S 3D 0.03
A1997G 8 Antigenic NS VP3 0.05
U2909A 8 Gatekeeper NS VP1 0.03
U882C 8 Capsid S VP4 0.02
G2782A 7 Antigenic NS VP1 0.01
G491A 7 Noncoding Noncoding 5′ UTR 0.14
G619U 7 Noncoding Noncoding 5′ UTR 0
C2609U 6 Capsid NS VP1 0.01
C2783A 5 Antigenic NS VP1 0
U4374C 5 2C S 2C 0.55
A3490G 4 2A NS 2A 0.02
C2291U 4 Capsid NS VP3 0.01
C2580U 4 Capsid S VP1 0.1
G1282A 4 Capsid NS VP2 0
U1641C 4 Capsid S VP2 0.68
U5811A 4 3C S 3C 0.14
U6693A 4 3D S 3D 0.31
a

Mutation presented as base in OPV2, position in OPV2 reference genome, and base in samples.

b

Number of individuals with each mutation present at a frequency of 5% or greater. The total number of individuals analyzed is 83.

c

Nonsynonymous (NS) or synonymous (S) mutations relative to the OPV2 reference genome.

d

Fraction of cVDPV genomes with each mutation.